Pharmaceuticals, Biotechnology and Life Sciences
DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company today announced that IMV Chief Executive…
WOBURN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BOD?src=hash" target="_blank"gt;#BODlt;/agt;–Frequency Therapeutics, a clinical-stage biotechnology company creating a new class of drugs based on small molecule…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced the pricing of its public offering of 5,600,000 shares of its…
OSAKA, Japan, AMSTERDAM, & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi,…
Expansion in EMEA follows the business’ success with Veeva CRM throughout North America, Latin America, and Asia Pacific PLEASANTON, Calif.–(BUSINESS…
OSAKA, Japan & AMSTERDAM, NL–(BUSINESS WIRE)–Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter “Shionogi”), announced it will…
Expansion in EMEA follows the business’ success with Veeva CRM throughout North America, Latin America, and Asia Pacific BARCELONA, Spain–(BUSINESS…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
Sandoz is resubmitting its Biologics License Application for a proposed biosimilar pegfilgrastim to the US FDA
–Addition of Experienced Executive to Leadership Team– NEWTOWN, Pa.–(BUSINESS WIRE)–Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a private biopharmaceutical company founded to…